The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global PAP and Paracetamol Market Research Report 2024
Synopsis
Paracetamol, also named acetaminophen, is an active ingredient in hundreds of over-the-counter (OTC) and prescription medicines. It relieves pain and fever. And, it is also combined with other active ingredients in medicines that treat allergy, cough, colds, flu, and sleeplessness.
The global PAP and Paracetamol market was valued at US$ 1356 million in 2023 and is anticipated to reach US$ 1999.4 million by 2030, witnessing a CAGR of 5.7% during the forecast period 2024-2030.
In the world the production of paracetamol is highly concentrated in China and India, the two countries occupy about 83.86% of the global production (China 59.02% and India 24.84%) in 2017, and their market share has been increasing in recent years.
This report aims to provide a comprehensive presentation of the global market for PAP and Paracetamol, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PAP and Paracetamol.
Report Scope
The PAP and Paracetamol market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global PAP and Paracetamol market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the PAP and Paracetamol companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Mallinckrodt
Anqiu Lu'an
Granules India
Zhejiang Kangle
Farmson
Hebei Jiheng
Novacyl
Anhui BBCA Likang
Anhui Fubore
SKPL
Atabay
Huzhou Konch
Changshu Huagang
Anhui Topsun
Sino Chemical
Segment by Type
Powder
Granules
Segment by Application
Tablet Drug
Granules Drug
Oral Solution
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of PAP and Paracetamol companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Paracetamol, also named acetaminophen, is an active ingredient in hundreds of over-the-counter (OTC) and prescription medicines. It relieves pain and fever. And, it is also combined with other active ingredients in medicines that treat allergy, cough, colds, flu, and sleeplessness.
The global PAP and Paracetamol market was valued at US$ 1356 million in 2023 and is anticipated to reach US$ 1999.4 million by 2030, witnessing a CAGR of 5.7% during the forecast period 2024-2030.
In the world the production of paracetamol is highly concentrated in China and India, the two countries occupy about 83.86% of the global production (China 59.02% and India 24.84%) in 2017, and their market share has been increasing in recent years.
This report aims to provide a comprehensive presentation of the global market for PAP and Paracetamol, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PAP and Paracetamol.
Report Scope
The PAP and Paracetamol market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global PAP and Paracetamol market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the PAP and Paracetamol companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Mallinckrodt
Anqiu Lu'an
Granules India
Zhejiang Kangle
Farmson
Hebei Jiheng
Novacyl
Anhui BBCA Likang
Anhui Fubore
SKPL
Atabay
Huzhou Konch
Changshu Huagang
Anhui Topsun
Sino Chemical
Segment by Type
Powder
Granules
Segment by Application
Tablet Drug
Granules Drug
Oral Solution
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of PAP and Paracetamol companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global PAP and Paracetamol Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Powder
1.2.3 Granules
1.3 Market by Application
1.3.1 Global PAP and Paracetamol Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Tablet Drug
1.3.3 Granules Drug
1.3.4 Oral Solution
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global PAP and Paracetamol Market Perspective (2019-2030)
2.2 PAP and Paracetamol Growth Trends by Region
2.2.1 Global PAP and Paracetamol Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 PAP and Paracetamol Historic Market Size by Region (2019-2024)
2.2.3 PAP and Paracetamol Forecasted Market Size by Region (2025-2030)
2.3 PAP and Paracetamol Market Dynamics
2.3.1 PAP and Paracetamol Industry Trends
2.3.2 PAP and Paracetamol Market Drivers
2.3.3 PAP and Paracetamol Market Challenges
2.3.4 PAP and Paracetamol Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top PAP and Paracetamol Players by Revenue
3.1.1 Global Top PAP and Paracetamol Players by Revenue (2019-2024)
3.1.2 Global PAP and Paracetamol Revenue Market Share by Players (2019-2024)
3.2 Global PAP and Paracetamol Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by PAP and Paracetamol Revenue
3.4 Global PAP and Paracetamol Market Concentration Ratio
3.4.1 Global PAP and Paracetamol Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by PAP and Paracetamol Revenue in 2023
3.5 PAP and Paracetamol Key Players Head office and Area Served
3.6 Key Players PAP and Paracetamol Product Solution and Service
3.7 Date of Enter into PAP and Paracetamol Market
3.8 Mergers & Acquisitions, Expansion Plans
4 PAP and Paracetamol Breakdown Data by Type
4.1 Global PAP and Paracetamol Historic Market Size by Type (2019-2024)
4.2 Global PAP and Paracetamol Forecasted Market Size by Type (2025-2030)
5 PAP and Paracetamol Breakdown Data by Application
5.1 Global PAP and Paracetamol Historic Market Size by Application (2019-2024)
5.2 Global PAP and Paracetamol Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America PAP and Paracetamol Market Size (2019-2030)
6.2 North America PAP and Paracetamol Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America PAP and Paracetamol Market Size by Country (2019-2024)
6.4 North America PAP and Paracetamol Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe PAP and Paracetamol Market Size (2019-2030)
7.2 Europe PAP and Paracetamol Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe PAP and Paracetamol Market Size by Country (2019-2024)
7.4 Europe PAP and Paracetamol Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific PAP and Paracetamol Market Size (2019-2030)
8.2 Asia-Pacific PAP and Paracetamol Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific PAP and Paracetamol Market Size by Region (2019-2024)
8.4 Asia-Pacific PAP and Paracetamol Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America PAP and Paracetamol Market Size (2019-2030)
9.2 Latin America PAP and Paracetamol Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America PAP and Paracetamol Market Size by Country (2019-2024)
9.4 Latin America PAP and Paracetamol Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa PAP and Paracetamol Market Size (2019-2030)
10.2 Middle East & Africa PAP and Paracetamol Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa PAP and Paracetamol Market Size by Country (2019-2024)
10.4 Middle East & Africa PAP and Paracetamol Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Mallinckrodt
11.1.1 Mallinckrodt Company Detail
11.1.2 Mallinckrodt Business Overview
11.1.3 Mallinckrodt PAP and Paracetamol Introduction
11.1.4 Mallinckrodt Revenue in PAP and Paracetamol Business (2019-2024)
11.1.5 Mallinckrodt Recent Development
11.2 Anqiu Lu'an
11.2.1 Anqiu Lu'an Company Detail
11.2.2 Anqiu Lu'an Business Overview
11.2.3 Anqiu Lu'an PAP and Paracetamol Introduction
11.2.4 Anqiu Lu'an Revenue in PAP and Paracetamol Business (2019-2024)
11.2.5 Anqiu Lu'an Recent Development
11.3 Granules India
11.3.1 Granules India Company Detail
11.3.2 Granules India Business Overview
11.3.3 Granules India PAP and Paracetamol Introduction
11.3.4 Granules India Revenue in PAP and Paracetamol Business (2019-2024)
11.3.5 Granules India Recent Development
11.4 Zhejiang Kangle
11.4.1 Zhejiang Kangle Company Detail
11.4.2 Zhejiang Kangle Business Overview
11.4.3 Zhejiang Kangle PAP and Paracetamol Introduction
11.4.4 Zhejiang Kangle Revenue in PAP and Paracetamol Business (2019-2024)
11.4.5 Zhejiang Kangle Recent Development
11.5 Farmson
11.5.1 Farmson Company Detail
11.5.2 Farmson Business Overview
11.5.3 Farmson PAP and Paracetamol Introduction
11.5.4 Farmson Revenue in PAP and Paracetamol Business (2019-2024)
11.5.5 Farmson Recent Development
11.6 Hebei Jiheng
11.6.1 Hebei Jiheng Company Detail
11.6.2 Hebei Jiheng Business Overview
11.6.3 Hebei Jiheng PAP and Paracetamol Introduction
11.6.4 Hebei Jiheng Revenue in PAP and Paracetamol Business (2019-2024)
11.6.5 Hebei Jiheng Recent Development
11.7 Novacyl
11.7.1 Novacyl Company Detail
11.7.2 Novacyl Business Overview
11.7.3 Novacyl PAP and Paracetamol Introduction
11.7.4 Novacyl Revenue in PAP and Paracetamol Business (2019-2024)
11.7.5 Novacyl Recent Development
11.8 Anhui BBCA Likang
11.8.1 Anhui BBCA Likang Company Detail
11.8.2 Anhui BBCA Likang Business Overview
11.8.3 Anhui BBCA Likang PAP and Paracetamol Introduction
11.8.4 Anhui BBCA Likang Revenue in PAP and Paracetamol Business (2019-2024)
11.8.5 Anhui BBCA Likang Recent Development
11.9 Anhui Fubore
11.9.1 Anhui Fubore Company Detail
11.9.2 Anhui Fubore Business Overview
11.9.3 Anhui Fubore PAP and Paracetamol Introduction
11.9.4 Anhui Fubore Revenue in PAP and Paracetamol Business (2019-2024)
11.9.5 Anhui Fubore Recent Development
11.10 SKPL
11.10.1 SKPL Company Detail
11.10.2 SKPL Business Overview
11.10.3 SKPL PAP and Paracetamol Introduction
11.10.4 SKPL Revenue in PAP and Paracetamol Business (2019-2024)
11.10.5 SKPL Recent Development
11.11 Atabay
11.11.1 Atabay Company Detail
11.11.2 Atabay Business Overview
11.11.3 Atabay PAP and Paracetamol Introduction
11.11.4 Atabay Revenue in PAP and Paracetamol Business (2019-2024)
11.11.5 Atabay Recent Development
11.12 Huzhou Konch
11.12.1 Huzhou Konch Company Detail
11.12.2 Huzhou Konch Business Overview
11.12.3 Huzhou Konch PAP and Paracetamol Introduction
11.12.4 Huzhou Konch Revenue in PAP and Paracetamol Business (2019-2024)
11.12.5 Huzhou Konch Recent Development
11.13 Changshu Huagang
11.13.1 Changshu Huagang Company Detail
11.13.2 Changshu Huagang Business Overview
11.13.3 Changshu Huagang PAP and Paracetamol Introduction
11.13.4 Changshu Huagang Revenue in PAP and Paracetamol Business (2019-2024)
11.13.5 Changshu Huagang Recent Development
11.14 Anhui Topsun
11.14.1 Anhui Topsun Company Detail
11.14.2 Anhui Topsun Business Overview
11.14.3 Anhui Topsun PAP and Paracetamol Introduction
11.14.4 Anhui Topsun Revenue in PAP and Paracetamol Business (2019-2024)
11.14.5 Anhui Topsun Recent Development
11.15 Sino Chemical
11.15.1 Sino Chemical Company Detail
11.15.2 Sino Chemical Business Overview
11.15.3 Sino Chemical PAP and Paracetamol Introduction
11.15.4 Sino Chemical Revenue in PAP and Paracetamol Business (2019-2024)
11.15.5 Sino Chemical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
